Apellis Pharmaceuticals, Inc. [APLS] has reported $396.6 million in revenue for year ended Dec 31, 2023.
Also Read:
The company said in a filing before the Securities and Exchange Commission that its loss for the year was $528.6 million.
Also Read:
Based in Waltham, Massachusetts, Apellis Pharmaceuticals, Inc. operates in the Manufacturing sector.
Related Articles: